IHE - Sixten Borg

Publications IHE Information Healthcare Deciders´ Forum

The Swedish Institute
for Health Economics
Box 2127
S-220 02 Lund
Visiting address:
Råbygatan 2
Phone: +46 46 - 32 91 00
info@ihe.se

Sixten Borg

M.Sc. Mathematics | Research Manager

Work areas

Sixten Borg has been a Senior Project Manager at IHE from 2003 to 2009, and returned to IHE in February 2010. He is a statistician and has been working with health economics, modelling and simulation methods since 1993.

Main activities:

Economic evaluation of pharmaceuticals and medical technology
Development of disease models and health economic models
Statistical methods within health economics

Sixten is a part time PhD student at the department of clinical sciences at Lund University, since 2011.

Selected presentations:

Swedish model of natural history and economic impact of COPD presented at the invitational conference “COPD, towards comprehensive, valid and transparent models to support future decision making”, 24 September 2011, and 28 September 2012, Amsterdam, Netherlands. Sixten Borg.

Modeling slowly progressing chronic diseases with exacerbations and their treatments: challenges in modeling Chronic Obstructive Pulmonary Disease (COPD). ISPOR 12th Annual European Congress, 24-27 October 2009, Paris, France. Maureen Rutten-van Molken, Talitha Feenstra, Sixten Borg.

A Maximum likelihood estimator of a Markov model for disease activity in chronic diseases that alternate between relapse and remission, for annually aggregated partial observations. Presented at the useR! 2008 conference, 12-14 August 2008, Dortmund, Germany. Sixten Borg.

Selected publications

Svensson J, Borg S and Nilsson P
Costs and quality of life in multiple sclerosis patients with spasticity
Acta Neurol Scand. 2013 May 18
[Epub ahead of print]

Borg S, Näslund I, Persson U & Ödegaard K
Budget impact analysis of surgical treatment for obesity in Sweden
Scandinavian Journal of Surgery 2012; 101(3): 190–197

Lökk J, Borg S, Svensson J, Persson U & Ljunggren G
Drug and treatment costs in Parkinson´s disease patients in Sweden
Acta Neurologica Scandinavica 2012 Feb; 125(2): 142-7

Borg S, Persson U, Jess T, Thompsen O, Ljung T, Riis L & Munkholm P.A
Maximum likelihood estimator of a Markov model for disease activity in Crohn´s disease and ulcerative colitis for annually aggregated partial observations
Medical Decision Making, 2010 Jan-Feb; 30(1): 132-142

Gerdtham UG, Andersson LF, Ericsson A, Borg S, Jansson SA, Rönmark E & Lundbäck B
Factors affecting chronic obstructive pulmonary disease (COPD)-related costs: a multivariate analysis of a Swedish COPD cohort
The European Journal for Health Economics 2009 May; 10(2): 217-226

Borg S, Glenngård AH, Österborg A & Persson U
The cost-effectiveness of treatment with erythropoietin compared to red blood cell transfusions for patients with chemotherapy induced anaemia: A Markov model
Acta Oncologica 2008; 47(6):1009-1017

Borg S, Persson U, Ödegaard K, Berglund G, Nilsson J-Å, Nilsson PM, Obesity, Survival, and Hospital Costs-Findings from a Screening Project in Sweden, Value in Health, 8(5):562–571, 2005.

Borg S, Ericsson Å, Wedzicha J, Gulsvik A, Lundbäck B, Donaldson GC & Sullivan SD. A Computer Simulation Model of the Natural History and Economic Impact of Chronic Obstructive Pulmonary Disease. Value Health. 2004 Mar-Apr;7(2):153-67.